InDex Pharmaceuticals presents at Redeye Growth Day 2020 26 May 2020 - Other press release May 26, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day 2020 on June 2 at 15.50 CET.

24 november 2020 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att VD Peter Zerhouni kommer att presentera bolaget den 26 november kl. 13:50 på Redeye Life Science Day.

Redeye AB with email address certifiedadviser@redeye.se and phone number +46 8 121 576 90 is the Company’s Certified Adviser. For more information, please visit www.indexpharma.com. InDex Pharmaceuticals in brief InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options. InDex Pharmaceuticals InDex Pharmaceuticals updates shareholders list. InDex Pharmaceuticals Holding AB (publ) today announced that the list of shareholders has been updated on the homepage with information as of August 30, 2019. InDex is based in Stockholm, Sweden. The company’s shares (ticker INDEX) are traded on Nasdaq First North Growth Market Stockholm.

1. Patientavgift specialistläkare
2. Snickeri leksand
3. Parken pizzeria umeå
4. Kardiologisk ambulatorium aalborg
5. Öppettider ystad djurpark
6. Haitis revolution
7. Fordon gymnasium
8. Erlend stavehaug
9. Val projekt
10. Hm monkey in the jungle

Presentationen liv Köp aktien InDex Pharmaceuticals Holding AB (INDEX). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid 2019-11-19 STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at 08:35 CET and at Avanza Börsdag at Operaterrassen, Karl XII:s torg in Stockholm at 11:15 CET on November 19. 2019-11-19 STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at 08:35 CET and at Avanza Börsdag at Operaterrassen, Karl XII:s torg in Stockholm at 11:15 CET on November 19. InDex Pharmaceuticals Holding AB (publ) is the parent company of the Group, which also includes InDex Pharmaceuticals AB and InDex Pharmaceuticals AB’s wholly owned subsidiary InDex Diagnostics AB. Redeye höjer sitt riktvärde i basscenariot för forskningsbolaget Index Pharma till 23,60 kronor från tidigare 14 kronor, en höjning med nästan 70 procent.

Redeye expects positive momentum in InDex shares as the market's focus shifts towards the phase III-study rather than the dilution related to the pending transaction. InDex is raising SEK InDex Pharmaceuticals presents at Redeye Life Science Day followed by a Q&A (replay from the 26th of November).

November 24, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at 13:50 CET on November 26.

We also comment on recent clinical news from the field of ulcerative colitis. November 24, 2020 - InDex Pharmaceuticals Holding AB today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at 13:50 CET on November 26. The presentation will be | January 31, 2021 24 oktober 2019 – InDex Pharmaceuticals Holding AB (publ) meddelar att VD Peter Zerhouni kommer att presentera bolaget på Redeye Investor After Work idag kl. 19.30 på … InDex Pharmaceuticals Holding Redeye expects positive momentum in InDex shares as the market's focus shifts towards the phase III-study rather than the dilution related to the pending transaction.

2019-11-19 · STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye

InDex is raising SEK 533m at SEK 1,2 per share.

InDex Pharmaceuticals in brief InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options. The Company’s lead asset is the drug candidate cobitolimod, which is in late stage clinical development for the treatment of moderate to severe active ulcerative colitis – a debilitating, chronic inflammation of InDex Pharmaceuticals presenterar på Redeye Growth Day 2020 tis, maj 26, 2020 08:00 CET. 26 maj 2020 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att VD Peter Zerhouni kommer att presentera bolaget på Redeye Growth Day 2020 den 2 juni, kl. 15.50.
Götgatan 16a stockholm

InDex Pharmaceuticals presents at Redeye Growth Day 2020 Tue, May 26, 2020 08:00 CET. May 26, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day 2020 on June 2 at 15.50 CET. InDex Pharmaceuticals presents today at Redeye Investor After Work Thu, Oct 24, 2019 08:01 CET. October 24, 2019 – InDex Pharmaceuticals Holding AB (publ) announced that CEO Peter Zerhouni will present the company at Redeye Investor After Work today at 19.30 CET at Scandic Rubinen, Kungsportsavenyen 24, in Gothenburg. November 24, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at 13:50 InDex Pharmaceuticals presenterar på Redeye Growth Day, 10 juni 2019 3 juni 2019 - Övrigt pressmeddelande 3 juni 2019 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att VD Peter Zerhouni kommer att presentera den senaste utvecklingen i bolaget på Redeye Growth Day på Haymarket by Scandic, Hötorget 13-15, i Stockholm den 10 juni, kl. 14.40. InDex Pharmaceuticals, vd Peter Zerhouni presenterar hos Redeye 27 april 2017.

Redeye reiterates its positive stance on InDex Pharmaceuticals following today's news that the  Index Pharmaceuticals: InDex Pharmaceuticals presents at Redeye Growth Day 2020. The presentation will also be available afterwards on  InDex Pharmaceuticals utvecklar cobitolimod, ett nytt läkemedel för "Redeye reiterates its positive stance on InDex Pharmaceuticals following the release of  Köp aktien InDex Pharmaceuticals Holding AB (INDEX). Hos Nordnet kan https://www.redeye.se/arena/posts/index-pharmaceticals-at-a-profitable-crossroads  Senaste nyheter om - InDex Pharmaceuticals Holding, aktieanalys, kursutveckling att VD Peter Zerhouni kommer att presentera bolaget på Redeye Growth Redeye expects positive momentum in InDex shares as the market's focus shifts towards the phase III- study rather than the dilution related to  Redeye reiterates its positive stance on InDex Pharmaceuticals following today's news that the European Patent Office has granted a patent  InDex Pharmaceuticals AB | 620 Follower auf LinkedIn InDex ”Redeye AB reiterates its positive stance on InDex Pharmaceuticals following the release of the  Tag: InDex Pharmaceuticals.
Vad driver dig

benchmark data svenska
firar britter i november
myofascial syndrome nhs
lediga lagerjobb rosersberg
angerratt mellan foretag

• iEi
• ONh
• lM
• iioU
• im
• sCZ

• Teddy winroth psykolog
• Pa uppdrag av
• Wiget media ab

InDex Pharmaceuticals updates shareholders list Fri, Mar 12, 2021 13:45 CET. March 12, 2021 – InDex Pharmaceuticals Holding AB (publ) today announced that the list of shareholders on the homepage has been updated with information as of February 26, 2021.

26 maj 2020 - InDex Pharmaceuticals Holding AB (publ) meddelar idag att VD Peter Zerhouni kommer att presentera bolaget på Redeye Growth Day 2020 den 2 juni, kl. 15.50. InDex Pharmaceuticals presenterar idag på Redeye Investor After Work tor, okt 24, 2019 08:00 CET. 24 oktober 2019 – InDex Pharmaceuticals Holding AB (publ) meddelar att VD Peter Zerhouni kommer att presentera bolaget på Redeye Investor After Work idag kl.

Köp aktien InDex Pharmaceuticals Holding AB (INDEX). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid

November 24, 2020 - InDex Pharmaceuticals Holding AB today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at 13:50 CET on November 26. The presentation will be | January 31, 2021 24 oktober 2019 – InDex Pharmaceuticals Holding AB (publ) meddelar att VD Peter Zerhouni kommer att presentera bolaget på Redeye Investor After Work idag kl. 19.30 på … InDex Pharmaceuticals Holding Redeye expects positive momentum in InDex shares as the market's focus shifts towards the phase III-study rather than the dilution related to the pending transaction.

Published 12 June 2019.